Recursion Pharmaceuticals to present at upcoming healthcare investor conferences in April and May 2026

Recursion Pharmaceuticals, a clinical-stage TechBio company focused on drug discovery using AI, announced its participation in two major investor conferences: the 25th Annual Needham Virtual Healthcare Conference on April 13, 2026, and the Bank of America Health Care Conference on May 12, 2026. These events provide Recursion an opportunity to showcase its AI-driven drug discovery platform and pipeline across oncology, rare diseases, neuroscience, and immunology. Investors can access webcasts of these presentations on Recursion's investor relations website. This participation highlights Recursion's ongoing efforts to engage with investors and advance its mission to develop innovative medicines faster and at scale.